I’ve been on an insulin pump for six and a half months. I use a Medtronic Minimed Paradigm Veo (without the CGM) and until this week I have used…
Tag: Insulin Pump
Medtronic announced the U.S. market launch of the first-of-its-kind mySentry™ Remote Glucose Monitor, which allows a parent or caregiver to monitor from another room a patient’s MiniMed Paradigm® REAL-Time Revel™ System. The remote glucose monitor also marks the launch of a new category of Connected Care solutions that will provide...
Medtronic announced the U.S. market launch of the first-of-its-kind mySentry™ Remote Glucose Monitor, which allows a parent or caregiver to monitor from another room a patient’s MiniMed Paradigm® REAL-Time Revel™ System. The remote glucose monitor also marks the launch of a new category of Connected Care solutions that will provide...
I’ve been having some troubles with my pump. Some of the problems are my fault, like forgetting to resume the pump after suspending it for a shower,…
Since its recent commercial launch, the Spring Universal Infusion Set has been particularly well received by parents of children with type 1 diabetes. Specifically, the following features were highly favored: the automatic all-in-one inserter (which gives young patients the independence to do their own site changes), the lightning-fast needle insertion...
So, I finally got a new insulin pump, the Minimed Paradigm 523, otherwise known as the Revel. I didn’t want to get it. I’ve been hoping…
The U.S. Food and Drug Administration (FDA) has given Medtronic approval of its Investigational Device Exemption (IDE) to conduct a pivotal in-home clinical trial protocol for the ASPIRE (Automation to Simulate Pancreatic InsulinREsponse) study of the MiniMed Paradigm® System featuring Low Glucose Suspend (LGS) automation. FDA approval of the IDE makes Medtronic’s ASPIRE study the first in-home pivotal trial of a closed loop system for type 1 diabetes management...
I don’t see that the company ethos has an understanding of the aesthetic I really want—the user-friendly, this-wouldn’t-look-weird-next-to-my-Louboutins* aesthetic.
The Animas corporation announced that Animas Vibe, the first and only continuous glucose monitoring (CGM)-enabled insulin pump system with Dexcom G4™ CGM technology, received the CE Mark of approval. The Animas® Vibe combines the features of an Animas insulin pump with the convenience of Dexcom CGM, which is the only sensor approved for up to seven days of wear...
Spring-Set Health Solutions Ltd., a subsidiary of Israel based company D. Medical Industries Ltd, has received a medical device license to market its Spring™ Universal Infusion Sets (formerly "Lighty DD Infusion Sets") in Canada...